On March 20, 2023, Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Hongyuan Pharmaceutical") was officially listed on the GEM of the Shenzhen Stock Exchange (stock code: 301246).
Hongyuan Pharmaceutical is one of the world's leading suppliers of nitroimidazole antibacterial APIs and intermediates, anti-herpes virus APIs and intermediates, and penicillin antibacterial drug intermediates. It is also one of the main manufacturers of lithium hexafluorophosphate, a lithium battery electrolyte material in the new energy field.
Hongyuan Pharmaceutical is the second company listing on the A-share market since 1999 in Huanggang, which shows a breakthrough in the area of capital markets for the last twenty years.
